'Vaccine production' presentation slideshows

Punnee Pitisuttithum - MBBS, DTM&H,FRCPT Faculty of Tropical Medicine , Mahidol University

Clinical Evaluation of Pandemic Live Attenuated Influenza Vaccine (PLAIV) Candidate Strain A/17/CA/2009/38 (H1N1) in Healthy Thais. Punnee Pitisuttithum - MBBS, DTM&H,FRCPT Faculty of Tropical Medicine , Mahidol University August 17,2011, Salaya,MU.

711 views • 62 slides

Veterinary Serum and Vaccine Research Institute in Egypt

Veterinary Serum and Vaccine Research Institute in Egypt. ( VSVRI ). Present and Future Prospect. By. Seham A. El-Zeedy Director of VSVRI. Historical. Background.

826 views • 49 slides

Veterinary Serum and Vaccine Research Institute in Egypt

Veterinary Serum and Vaccine Research Institute in Egypt. ( VSVRI ). Present and Future Prospect. By. Seham A. El-Zeedy Director of VSVRI. Historical. Background.

986 views • 49 slides

Adult Immunization: 2013 Update

Adult Immunization: 2013 Update . Robert H. Hopkins, Jr., MD, FACP, FAAP Professor of Internal Medicine and Pediatrics Director, Division of General Internal Medicine Director, Internal Medicine-Pediatrics Residency UAMS College of Medicine. Opportunity and Reward.

611 views • 42 slides

Procurement under the Terms and Conditions of the Advance Market Commitment

Procurement under the Terms and Conditions of the Advance Market Commitment. AMC Pre-tender meeting UNICEF SD, 26 August 2009 Tania Cernuschi and Ann Ottosen. Presentation Overview. AMC Procedures Memorandum Request for Proposal (Call for Offers) Supply Agreement Terms and Conditions.

569 views • 41 slides

Procurement under the Terms and Conditions of the Advance Market Commitment

Procurement under the Terms and Conditions of the Advance Market Commitment. AMC Pre-tender meeting UNICEF SD, 26 August 2009 Tania Cernuschi and Ann Ottosen. Presentation Overview. AMC Procedures Memorandum Request for Proposal (Call for Offers) Supply Agreement Terms and Conditions.

413 views • 41 slides

IAPCOI-2011-13: Rollout plan

IAPCOI-2011-13: Rollout plan . July 16, 2011 IAP HQ, Mumbai. Vipin M. Vashishtha, MD, FIAP Convener, 2011-13 vmv@manglahospital.org. Plan of action: . I. Objectives II. Operational issues III. Recommendations IV. Collaborations V. Future Activities: Recommendations Surveillance

480 views • 31 slides

Modern Clinical Applications of Cultured Cells

Modern Clinical Applications of Cultured Cells. Mammalian cell products: established and potential Major innovative development of cell culture: 1. Viral vaccine 2. Monoclone antibodies 3. Recombinant proteins 4. Cell and tissue transplant. 5. Drug screening and discovery

389 views • 30 slides

Outline

Drug Regulatory Systems Strengthening (RSS) WHO Technical Briefing Seminar on Essential Medicines and Health Products 31 October 2013 WHO Headquarters, Geneva, Salle M 505 Dr Claudia P Alfonso. Outline. Global overview of vaccine production and immunization

363 views • 25 slides

312 views • 25 slides

Outline

Drug Regulatory Systems Strengthening (RSS) WHO Technical Briefing Seminar on Essential Medicines and Health Products 31 October 2013 WHO Headquarters, Geneva, Salle M 505 Dr Claudia P Alfonso. Outline. Global overview of vaccine production and immunization

309 views • 25 slides

OVERVIEW OF THE NATIONAL INFLUENZA VACCINE SUMMIT

407 views • 25 slides

Pandemic Influenza; A Harbinger of Things to Come

Pandemic Influenza; A Harbinger of Things to Come. Michael T Osterholm PhD, MPH Director, Center for Infectious Disease Research and Policy Associate Director, DHS National Center for Food Protection and Defense and Professor, School of Public Health University of Minnesota.

399 views • 24 slides

Universal Influenza Immunization in Adults

327 views • 18 slides

Expanded Influenza Vaccination Recommendations: Developing an Implementation Strategy

250 views • 15 slides

Vaccine Manufacturing

Vaccine Manufacturing. Joe Bielitzki NanoScience Technology Center University of Central Florida Orlando, Florida jbielitz@mail.ucf.edu. Vaccine need. Infectious diseases of public health interest Rotavirus Measles, mumps, rubella Diphtheria, pertussis, tetanus Polio Emerging diseases

313 views • 13 slides

Vaccine Manufacturing Technology and Services: World Market

Bharat Book Presents"Vaccine Manufacturing Technology and Services: World Market 2013-2023"Our study lets you assess sales data at overall world market, submarket and national level. There you find the most promising and lucrative areas in the production of vaccines, helping your research and analyses.

289 views • 12 slides

Rubella rash

Rubella rash. Rubella virus. MRC-5 cells. Operator. Vaccine production. Cytopathic effect of rubella virus. Filling. Quality control. Final product. Transport. Incidence and efficiency (Croatia 1976-2008).

331 views • 11 slides

Chapter Sixteen

Chapter Sixteen. Science, Technology, and Global Health. The Need for New Products. Characteristics of new technologies must reflect the following: Most important target groups are poor people Quality of care and injection safety is often low

182 views • 9 slides

an introduction for Process Development

an introduction for Process Development

39 views • 3 slides